Spirometry Sample Clauses

Spirometry. Spirometry will be performed as noted in the Schedule of Events and in accordance with the current American Thoracic Society recommendations for the performance and interpretation of tests. Two puffs of albuterol or levalbuterol (Xopenex) will be administered 15 minutes to 2 hours prior to spirometry during all study visits. Subjects that have already self-administered albuterol or levalbuterol (Xopenex) within 2 hours prior to spirometry do not need to re-administer; however those that have taken a long-acting bronchodilator (e.g., salmeterol, formoterol as contained in Advair®, Symbicort®, or similar medications) would be required to administer albuterol or levalbuterol (Xopenex) 15 minutes to 2 hours prior to spirometry at the visit. Detailed instructions on the order of procedures will be provided in supplemental study materials.

Spirometry. Spirometry included forced expiratory volume in 1 s (FEV1), forced vital capacity (FVC), FEV1/FVC ratio and maximum expiratory flow at 50% of FVC (MEF50). Bronchodilator response was not assessed. Spirometry was performed on the same day as the screening CTand was repeated after 3 years of follow-up. All participants with an FEV1/FVC ratio <70% at baseline were considered to have airflow obstruction. Statistical evaluation Mean and SD values were calculated for normally distributed data and median and IQR for non-normally distributed data. The Student t test and c2 test were used to detect differences between groups as appropriate. ▇▇▇▇▇▇▇ correlations were used to establish associations between normally distributed variables at baseline. — Previous research has shown that lung function decline is linear over a time span of 3 years.20 FEV1, FEV1/FVC and MEF50 values over time were therefore analysed using random inter- cept, random slope linear mixed model analysis. The time of observation/intercept was chosen as random parameters; all other parameters were considered to be fixed. The choice of the covariance matrix fell on the unstructured one, based on a comparison of the 2 restricted log likelihood values. The results of the analyses for FEV1/FVC and MEF50 are shown in the online supplement. The baseline low-attenuation area at CT (Perc15) was the main explanatory factor. We adjusted for pack- years smoked, smoking status, centre, height, body mass index and age to obtain corrected lung function parameters. We inserted interactions between Perc15 and absence/presence of airflow obstruction, between Perc15 and smoking status and between Perc15 and pack-years to test whether the association between Perc15 and lung function decline was also dependent on the presence of baseline obstruction or on exposure to tobacco.21 Decline in lung function was calculated by subtracting corrected — =

Spirometry. Spirometry will be performed in accordance with the current American Thoracic Society recommendations for the performance and interpretation of tests for all participating CF subjects. If spirometry is performed at the same visit as sputum induction, the spirometry procedure should be performed in concert with the sputum induction procedure. Spirometry should be performed within 15 ±5 minutes of administration of the short-acting bronchodilator (e.g., albuterol) required for the induction procedure and prior to the induction procedure itself. If sputum induction is not being performed, short-acting bronchodilator (e.g., albuterol) should still be administered prior to the spirometry procedure as noted above.

Spirometry. Starting at age 40 and each physical examination thereafter will include the prostate specific antigen (PSA) testing.

Spirometry. 5.4.16.1 Staff performing spirometry must have completed a live NIOSH- approved spirometry course within the last five (5) years. 5.4.16.2 The name of the staff member performing spirometry must be clearly written on the spirogram. 5.4.16.3 Testing must be consistent with the NIOSH recommended procedures (see ▇▇▇▇://▇▇▇.▇▇▇.▇▇▇/niosh/docs/2004- 154c/pdfs/2004-154c-ch4.pdf and pages 22-23 in the Clinical Testing Procedures. 5.4.16.4 Spirometry must be repeated up to eight times to obtain at least three technically acceptable tracings which include two tracings with FEV1 and FVC values that differ by no more than 5%.

Spirometry. ‌ Spirometry will be performed as noted in the Schedule of Events and in accordance with the current American Thoracic Society recommendations for the performance and interpretation of tests. Predicted equations for the computation of FEV1 and FVC % predicted will utilize the reference equations by ▇▇▇▇▇▇▇▇▇ (42). Subjects who routinely use bronchodilators should use them prior to spirometry as noted below:

Spirometry. Spirometry will be performed as noted in the Schedule of Events study visits by participants 4 years of age and older at the time of randomization; who are able to reproducibly perform spirometry [31]. Spirometry will be performed in accordance with the current American Thoracic Society recommendations for the performance and interpretation of tests. The same spirometry equipment should be used for the duration of the study whenever possible. Raw lung function measurements will be recorded. Percent of predicted measurements will be calculated centrally. Bronchodilator use at each visit should be consistent throughout the study for reproducible results. For subjects that routinely use bronchodilator reference the standard guidelines, as noted below: ▪ Subjects who routinely use short acting inhaled bronchodilators should use them 15 minutes to 2 hours prior to PFTs during study visits. ▪ Subjects who routinely use long acting bronchodilator agents should use them 15 minutes to 6 hours prior to PFTs during study visits. If a bronchodilator is not used prior to spirometry at Visit 2 or Combined Visit 1 and Visit 2, subjects should not use a bronchodilator prior to spirometry at subsequent visits.

Spirometry a. Respirator Physical for silica exposed personnel and based on OSHA review for personnel wearing masks b. PPD testing which confirmation of result via phone/web within 48-72 hours post application for silica Exposure Personnel c. Chest xray with B read at one of 5 statewide facilities for silica exposure personnel (up to 10/day) b. Onsite Audiometry Testing for up to 8 hours of testing and up to 120 audiometric screenings - $1,800.00 c. Onsite Audiometry testing for up to 3 hours of testing and up to 48 audiometric screenings - $1,200.00 d. Onsite qualitative FIT test per test - $50.00 e. Onsite Quantitative FIT testing per test for ½ and full masks - $80.00 f. Additional Chest Xray beyond 10 per day each - $150.00 g. Work readiness review - $120.00 h. Online ODHS review via ▇▇▇.▇▇▇▇▇▇▇▇▇▇.▇▇▇ - $35.00 i. Paper OSHA review delivered to our facility - $35.00 j. Physician Fee or PLHCP per day is included in above pricing. k. Technician only – up to 8 hours of testing is included in pricing above. l. Equipment Shipment Fee – non. m. PPD test included in above testing for Silica exposure individuals. n. Chest Xray with B read included in daily fee up to 10/day. o. OSHA Review Responses and FIT for duty paperwork will be available and pushed to Vermont State Personnel that need results via our HIPAA compliance employer portal. p. Contractor requests historical audiometric data on all individuals at least 1 month prior to the initiation of screening to ensure prompt reporting of all potential STS charges.

Spirometry. Spirometry is a safe and painless respiratory examination that measures the amount of air contained in the lungs as well as the flow of air expelled during a voluntary and maximal expiration. This respiratory examination is common in the diagnosis of asthma in children and adults as well as in the diagnosis of Chronic Obstructive Pulmonary Disease (COPD).